Influence of common cardiac drugs on gastroesophageal reflux disease: Multicenter questionnaire survey

International Journal of Clinical Pharmacology and Therapeutics

Volumn 49, Issue 9, 2011, Pages 555-563

  Nakaji, G ^a   Fujihara, M ^a   Fukata, M ^a   Yasuda, S ^a   Odashiro, K ^a   Maruyama, T ^a   Akashi, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Adverse effects; Calcium channel blockers; Gastroesophageal reflux disease; Questionnaire survey; Wawrfarin

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC AGENT; GASTROINTESTINAL AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DOSE TIME EFFECT RELATION; FEMALE; FREQUENCY SCALE FOR SYMPTOMS OF GERD; GASTROESOPHAGEAL REFLUX; HEART FAILURE; HUMAN; INCIDENCE; LUNG INFARCTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PERCUTANEOUS CORONARY INTERVENTION; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; STROKE; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CALCIUM CHANNEL BLOCKERS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; WARFARIN;

EID: 80052987385     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201558     Document Type: Article

References (28)

1. Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009; 44: 518-534. doi:10.1007/s00535-009-0047-5 PubMed
2. Sucuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol. 2007; 42: 1-15. doi:10.1007/s00535- 006-1990-z PubMed (Pubitemid 46357245)
3. Flook NW, Wiklund I. Accounting for the effect of GEM) symptoms on patients' health-related quality of life: supporting optimal disease management by primary care physicians. Int J Clin Pract 2007; 61: 2071-2078. doi:10.1111/j.1742-1241.2007.01586.x PubMed (Pubitemid 350077407)
4. Glise H, Hallerbäck B. Johansson B. Quality-of-life assessments in evaluation of laparoscopic Rosetti fundoplication. Surg Endosc. 1995; 9: 183-188., discussion 188-189. PubMed doi:10.1007/BP00191963
5. Katz PO, Castell DO. Approach to the patient with unexplained chest pain. Am J Gastroenterol. 2000; 95 (Suppl): 54-58. doi:10.1016/S0002-9270(00)01072-8 PubMed
6. Mohd H, Qua CS, Wong CH, Azman W, Goh KL. Non-cardiac chest pain: prevalence of reflux disease and response to acid suppression in an Asian population. J Gastroenteml Hepatol. 2009; 24: 288-293. doi: 10.1111/j.1440-1746. 2008.05702.x PubMed
7. Kusana M, Shimoyama K, Sugimoto S, Kawamura O, Maeda M, Minashi K, Kuribayashi S, Higuchi T, Zai H, Ino K, Horikoshi T, Sugiyama T, Toki M, Ohwada T, Mori M. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol. 2004; 39: 888-891. doi:10.1007/s00535-004-1417-7 PubMed (Pubitemid 39409671)
8. Kusano M, Shimoyama Y, Kawamura O, Maeda M, Kuribayashi S, Nagoshi A, Zai H, Moki F, Horikoshi T, Toki M, Sugimoto S, Mori M. Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients. Dig Dis Sci. 2007; 52: 1673-1677. doi:10.1007/s106 20-006-9674-3 PubMed
9. Furukawa N, Iwakiri R, Kayama T, Okamoto K, Yoshida T, Kashiwagi Y, Ohyama T, Noda T, Sakata H, Fujimoto K. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol. 1999; 34: 441-444. doi: 10. 1007/s005350050293 PubMed
10. Mishima l, Adachi K, Arima N, Amano K, Takashima T, Moritani M, Furuta K, Kinoshita Y. Prevalence of endoscopicaliy negative and positive gastro esophageal reflux disease in the Japanese. Scand J Gastroenterol. 2005; 40: 1005-1009. doi:10.1080/00365520510023260 PubMed
11. Jank S, Bertsche T, Herzog W, Haefeli WE. Patient knowledge on oral anticoagulants: results of a questionnaire survey in Germany and comparison with the literature. Int J Chin Pharmacol Ther. 2008; 46: 280-288. PubMed (Pubitemid 351890730)
12. Miyamoto M, Haruma K, Kuwabara M, Nagano M, Okamoto T, Tanaka M. High incidence of newly-developed gastroesophageal reflux disease in the Japanese community: a 6-year follow-up study. J Gastroenterol Hepatol. 2008; 23: 393-397. doi:10.1111/j.1440-V746.2007.05043.x PubMed (Pubitemid 351342060)
13. Hongo M, Traube M, McCallum RW. Comparison of effects of nifedipine, propanthelune bromide, and the combination on esophageal motor function in normal volunteers. Dig Dis Sci. 1984; 29: 300-304. doi:10.1007/BF01318513 PubMed (Pubitemid 14131550)
14. Wu JH, Chang CS, Chen GH, Poon SK, Ko CW. Pelodipine does not increase the reflux episodes in patients with gastroesophageal reflux disease. Hepatogastroenterology. 2000; 47: 1328-1331. PubMed
15. Hughes J, Lockhart J, Joyce A. Do calcium antagonists contribute to gastro-oesophageal reflux disease and concomitant noncardiac chest pain? Br J Chin Pharmacol. 2007; 64: 83-89. doi:10.1111/j.1365-2125.2007.02851.x PubMed (Pubitemid 46934417)
16. McCarthy DM, Denis M. Do drugs or bugs cause GERD? J Clin Gastroenterol. 2007; 41 (Suppl 2): 559-563. doi:10.1097/MCG.0b013e31803238fb
17. Gaginella TS, Maxfield DL. Calcium-channel blocking agents and chest pain. Drug Intell Clin Pharm. 1988; 22: 623-625. PubMed
18. 2 receptor blockers and proton pump inhibitors with warfarin in general practice. Postgrad Med J. 1999; 75: 721-722. PubMed
19. Lanas A, Garcia-Rodriguez LA, Arroyo MT, Gomollón F, Feu F, Ganzález-Pérez A, Zapata E, Bástida G, Rodrigo L, Santolaria S, Güell M, De Argila CM, Quintero E, Borda F, Piqué JM; Asociación Española de Gastroenterologia. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 2006; 55: 1731-1738. doi:10.11 36/gut.2005.080754 PubMed
20. Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med. 1993; 95: 315-328. doi:10.1016/0002-9343(93)90285-W PubMed (Pubitemid 23270290)
21. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S; Italian Study on Complications of Oral Anticoagulant Therapy. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet. 1996; 348: 423-428. doi:10.1016/S0140-6736(96)01109-9 PubMed (Pubitemid 26267872)
22. Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritren K, Riley S, Lundell L. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998; 33: 1023-1029. doi: 10.1080/003655298750026697 PubMed (Pubitemid 28505643)
23. Johnsson F, Weywadt L, Solhaug JH, Hernqvist H, Bengtsson L. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol. 1998; 33: 15-20. doi:10.1080/00365529850166 149 PubMed
24. Danjo A, Yamaguchi K, Fujimoto K, Saitoh T, Inamori M, Ando T, Shimatani T, Adachi K, Kinjo F, Kuribayashi S, Mitsufuji S, Fujiwara Y, Koyama S, Akiyama J, Takagi A, Manabe N, Miwa H, Shimoyama Y, Kusano M. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres. J Gastroenterol Hepatol. 2009; 24: 633-638. doi:10.1111/j.1440- 1746.2008.05747.x PubMed
25. Manabe N, Haruma K, Hata J, Kamada T, Kusunoki H. Differences in recognition of heartburn symptoms between Japanese patients with gastroesophageal reflux, physicians, nurses, and healthy lay subjects. Scand J Gastroenterol. 2008; 43: 398-402. doi:10. 1080/0036552070181507 PubMed
26. Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology. 2004; 126: 660-664. doi:10.1053/j.gastro.2003.12.001 PubMed (Pubitemid 38298313)
27. Lin M, Gerson LB, Lascar R, Davila M, Triada-filopoulos G. Features of gastroesophageal reflux disease in women. Am J Gastroenterol. 2004; 99: 1442-1447. doi:10.1111/j.1572-0241.2004.041 47.x PubMed
28. Nakaji G, Fujihara M, Fukata M, Yasuda S, Odashiro K, Maruyama T, Akashi K. Influence of cardiac drugs including warfarin on gastro esophageal reflux disease: results of formulated questionnaire study (abstract). Circ J. 2010; 74 (Suppl. 1,): 795.